Publications by authors named "B M Deepak"
Maternal health and obstetric complications of genetic neuromuscular disorders in pregnancy: A systematic review.
Eur J Obstet Gynecol Reprod Biol
January 2025
Article Synopsis
- Genetic neuromuscular disorders significantly impact muscle function and present challenges during pregnancy, necessitating a review of related obstetric outcomes.
- A systematic analysis of 28 studies revealed common complications such as polyhydramnios, preterm labor, and increased rates of cesarean sections among pregnant women with disorders like myotonic dystrophy and spinal muscular atrophy.
- Effective management of these high-risk pregnancies requires collaboration between neurologists and obstetricians, alongside further research to establish standardized care protocols.
Introduction: Prostate-specific antigen (PSA) is a key marker for prostate cancer screening, but its utility is debated, prompting exploration of PSA derivatives for improved accuracy. While racial variations in serum PSA levels are documented, limited data exists for the Indian population. Given increasing life expectancy and heightened awareness of prostate cancer, this study aims to establish age-specific PSA ranges in an Indian cohort, contributing vital insights for population-specific screening and diagnosis.
View Article and Find Full Text PDFIntroduction Caregivers of individuals with head, neck, and face cancer play a pivotal role in providing support, yet they face distinct challenges. This study aims to explore caregiving experiences and consequences among this population. Methods A multicentric cross-sectional study involving 200 caregivers using a convenience sampling method was conducted in Pune.
View Article and Find Full Text PDFThe Star fruit (Averrhoa carambola L.) was globally distributed, particularly in countries like China, India, Indonesia and was renowned for its abundant vitamin, mineral and antioxidant content (Reddy et al., 2023).
View Article and Find Full Text PDFArticle Synopsis
- Personalized medicine is advancing with RNA therapy, providing new treatment options for cardiovascular diseases (CVD) by targeting the human genome.
- Current research shows promise in using RNA therapies for diagnosing and preventing heart-related conditions, but only a few treatments are in clinical trials or FDA-approved.
- Key challenges include delivering drugs effectively to cells, managing immune responses, and ensuring overall safety, which need to be addressed for RNA therapies to progress.